Yuan Xu - 04 Jan 2022 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
Issuer symbol
XLO
Transactions as of
04 Jan 2022
Transactions value $
$0
Form type
3
Filing time
06 Jan 2022, 17:40:23 UTC
Previous filing
05 Aug 2021
Next filing
03 Jun 2022

No securities are beneficially owned.